Hypera SA
BOVESPA:HYPE3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.8
36.23
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HYPE3 stock under the Base Case scenario is 38.95 BRL. Compared to the current market price of 18.65 BRL, Hypera SA is Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hypera SA
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
Valuation History
Historical valuation for HYPE3 cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hypera SA
Balance Sheet Decomposition
Hypera SA
Current Assets | 8.8B |
Cash & Short-Term Investments | 3.2B |
Receivables | 3.4B |
Other Current Assets | 2.2B |
Non-Current Assets | 17.1B |
Long-Term Investments | 138.2m |
PP&E | 3.7B |
Intangibles | 11.7B |
Other Non-Current Assets | 1.5B |
Current Liabilities | 4.8B |
Accounts Payable | 374.9m |
Accrued Liabilities | 513.2m |
Short-Term Debt | 15.6m |
Other Current Liabilities | 3.9B |
Non-Current Liabilities | 8.8B |
Long-Term Debt | 8.4B |
Other Non-Current Liabilities | 363.7m |
Earnings Waterfall
Hypera SA
Revenue
|
7.8B
BRL
|
Cost of Revenue
|
-3B
BRL
|
Gross Profit
|
4.7B
BRL
|
Operating Expenses
|
-2.6B
BRL
|
Operating Income
|
2.2B
BRL
|
Other Expenses
|
-621.4m
BRL
|
Net Income
|
1.6B
BRL
|
Free Cash Flow Analysis
Hypera SA
BRL | |
Free Cash Flow | BRL |
HYPE3 Profitability Score
Profitability Due Diligence
Hypera SA's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Hypera SA's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
HYPE3 Solvency Score
Solvency Due Diligence
Hypera SA's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
Hypera SA's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HYPE3 Price Targets Summary
Hypera SA
According to Wall Street analysts, the average 1-year price target for HYPE3 is 30.16 BRL with a low forecast of 24.24 BRL and a high forecast of 37.8 BRL.
Dividends
Current shareholder yield for HYPE3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one HYPE3 stock under the Base Case scenario is 38.95 BRL.
Compared to the current market price of 18.65 BRL, Hypera SA is Undervalued by 52%.